EUROLAB
iso-10993-14-degradation-testing
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2130 Endotoxin TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2255 Acute Systemic ToxicityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityASTM F756 Assessment of Hemolytic PropertiesEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation and Reference MaterialsISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-15 Toxicokinetic StudyISO 10993-16 Toxicokinetic Study ProtocolISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-29 Extraction ConditionsISO 10993-3 Genotoxicity TestingISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-33 Biological Evaluation of Degradation ProductsISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-7 Ethylene Oxide ResidualsISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

Comprehensive Guide to ISO 10993-14 Degradation Testing Laboratory Testing Service by Eurolab

ISO 10993-14 is a globally recognized standard that governs the degradation testing of medical devices and materials. This standard is part of the larger ISO 10993 series, which covers biological evaluation of medical devices. The 14th part of this series specifically focuses on degradation testing, which is essential for ensuring the safety and performance of medical devices.

Legal and Regulatory Framework

The legal and regulatory framework surrounding ISO 10993-14 Degradation Testing testing is governed by various international and national standards, including:

  • ISO 10993:2009 (Biological evaluation of medical devices)
  • ASTM F748:2014 (Standard Practice for Selecting Generic Biological Test Data for Materials and Products)
  • EN ISO 10993-1:2018 (Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process)
  • TSE (Turkish Standards Institution) EN ISO 10993-14:2020
  • These standards provide the framework for conducting degradation testing, ensuring that medical devices meet safety and performance requirements.

    International and National Standards

    The following international and national standards apply to ISO 10993-14 Degradation Testing testing:

  • ISO 10993 (Biological evaluation of medical devices)
  • ASTM F748:2014 (Standard Practice for Selecting Generic Biological Test Data for Materials and Products)
  • EN ISO 10993-1:2018 (Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process)
  • TSE (Turkish Standards Institution) EN ISO 10993-14:2020
  • Standard Development Organizations

    Standard development organizations, such as ISO (International Organization for Standardization), ASTM (American Society for Testing and Materials), and CEN (European Committee for Standardization), play a crucial role in developing and maintaining standards. These organizations ensure that standards are up-to-date, relevant, and meet the needs of industry stakeholders.

    Evolution and Update of Standards

    Standards evolve and get updated as new research, technologies, and regulations emerge. This ensures that standards remain relevant and effective in ensuring product safety and performance.

    Standard Numbers and Scope

    The following standard numbers and scope apply to ISO 10993-14 Degradation Testing testing:

  • ISO 10993 (Biological evaluation of medical devices)
  • Scope: Biological evaluation of medical devices

    Number of parts: 22 (including Part 1, which covers general requirements)

  • ISO 10993-14 (Degradation testing)
  • Scope: Degradation testing of materials and products used in medical devices

    Number of parts: 1

    Standard Compliance Requirements

    Compliance with these standards is mandatory for medical device manufacturers seeking to ensure the safety and performance of their products.

    Standard-Related Information Conclusion

    In conclusion, ISO 10993-14 Degradation Testing testing is a crucial aspect of ensuring product safety and performance. Compliance with relevant international and national standards is essential for medical device manufacturers. Understanding the legal and regulatory framework surrounding this testing service is vital for businesses operating in this industry.

    ---

    ISO 10993-14 Degradation Testing testing is a critical requirement for medical device manufacturers seeking to ensure product safety and performance. This section explains why this specific test is needed, the business and technical reasons for conducting it, and the consequences of not performing it.

    Why This Test Is Needed

    This test is essential for ensuring that medical devices meet safety and performance requirements. Degradation testing assesses the chemical and physical changes in materials and products used in medical devices over time. This information helps manufacturers identify potential issues before they affect patient safety or device performance.

    Business and Technical Reasons for Conducting This Test

    The following business and technical reasons support the need for ISO 10993-14 Degradation Testing testing:

  • Ensures product safety and performance
  • Complies with regulatory requirements
  • Demonstrates quality and reliability
  • Enhances customer confidence and trust
  • Supports innovation and research development
  • Consequences of Not Performing This Test

    Not performing degradation testing can lead to:

  • Product recalls due to non-compliance or inadequate design
  • Damage to brand reputation and loss of market share
  • Increased regulatory scrutiny and fines
  • Reduced patient safety and device performance
  • Industries and Sectors That Require This Testing

    The following industries and sectors require ISO 10993-14 Degradation Testing testing:

  • Medical devices (e.g., implants, surgical instruments)
  • Pharmaceuticals (e.g., packaging materials)
  • Biotechnology (e.g., bioimplants)
  • Risk Factors and Safety Implications

    Degradation testing helps identify potential risks associated with medical device design, materials, or manufacturing processes. This information enables manufacturers to take corrective action before they affect patient safety.

    ---

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers